Search details
1.
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Lancet
; 396(10257): 1090-1100, 2020 10 10.
Article
in English
| MEDLINE | ID: mdl-32966830
2.
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
N Engl J Med
; 379(22): 2108-2121, 2018 11 29.
Article
in English
| MEDLINE | ID: mdl-30345906
3.
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(1): 44-59, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31786121
4.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27406346
5.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Article
in English
| MEDLINE | ID: mdl-27406347
6.
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply.
N Engl J Med
; 380(10): 987-988, 2019 03 07.
Article
in English
| MEDLINE | ID: mdl-30855757
7.
Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer?
NMR Biomed
; 27(7): 760-73, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24798066
8.
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer.
NPJ Breast Cancer
; 8(1): 108, 2022 Sep 19.
Article
in English
| MEDLINE | ID: mdl-36123366
9.
Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
Clin Breast Cancer
; 21(6): 539-551, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34154926
10.
Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice.
Curr Oncol
; 28(4): 2741-2752, 2021 07 17.
Article
in English
| MEDLINE | ID: mdl-34287291
11.
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel-Treated Advanced Triple-Negative Breast Cancer.
J Natl Cancer Inst
; 113(12): 1733-1743, 2021 11 29.
Article
in English
| MEDLINE | ID: mdl-34097070
12.
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study.
J Natl Cancer Inst
; 113(8): 1005-1016, 2021 08 02.
Article
in English
| MEDLINE | ID: mdl-33523233
13.
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinoma.
Oncoimmunology
; 9(1): 1824645, 2020 10 05.
Article
in English
| MEDLINE | ID: mdl-33101774
14.
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
JAMA Oncol
; 6(9): 1355-1362, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-32701140
15.
Comparative effectiveness of first-line nab-paclitaxel versus paclitaxel monotherapy in triple-negative breast cancer.
J Comp Eff Res
; 8(14): 1173-1185, 2019 10.
Article
in English
| MEDLINE | ID: mdl-31394922
16.
DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response.
Tomography
; 3(1): 23-32, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-28691102
17.
Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report.
Clin Breast Cancer
; 7(4): 342-4, 2006 Oct.
Article
in English
| MEDLINE | ID: mdl-17092404
18.
Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.
Transl Oncol
; 9(1): 8-17, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26947876
19.
The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.
Cancer Epidemiol Biomarkers Prev
; 14(8): 1883-9, 2005 Aug.
Article
in English
| MEDLINE | ID: mdl-16103431
20.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Clin Cancer Res
; 21(13): 2911-5, 2015 Jul 01.
Article
in English
| MEDLINE | ID: mdl-25712686